astrazeneca china

Removing Early Barriers To Drugs For Neglected Diseases

DNDi has formed a consortium with four pharmaceutical companies to hasten the development of drugs for leishmaniasis and Chagas disease.

Pharmaceutical IT Asia Congress To Highlight Digital Healthcare Innovation

Oxford Global’s Pharmaceutical IT Asia Congress will take place from March 25-26, 2014 in Singapore..

AstraZeneca, Fudan University To Collaborate In China

AstraZeneca and Fudan University are set to collaborate on cardiovascular research in China.

Ironwood, AstraZeneca To Develop Linaclotide In China

AstraZeneca and Ironwood Pharmaceuticals, Inc. announced this week an agreement to co‐develop and co‐commercialize Ironwood’s linaclotide in China.

AstraZeneca Acquires Chinese Generics Maker, Guangdong BeiKang Pharma

AstraZeneca will acquire Guangdong BeiKang Pharmaceutical Company Ltd, a privately-owned generics manufacturing company in Guangdong province, China.

AstraZeneca Invests US$200m Into Manufacturing Facility In China Medical City

AstraZeneca today announced a US$200 million investment in a new manufacturing facility, located in China Medical City, Taizhou, Jiangsu province in Eastern China.